array(3) { ["company_details"]=> array(13) { ["name"]=> string(25) "Gsk Consumer Health, Inc." ["slug"]=> string(32) "4abba-us-gsk-consumer-health-inc" ["logo"]=> string(84) "https://images.businessradar.com/linkedin_logos/8434ac9a-9bf2-4877-a3a0-a4039c237204" ["description"]=> string(518) "GSK Consumer Healthcare is a global business that discovers, develops, and manufactures innovative consumer healthcare products. It is an associate of GlaxoSmithKline plc, one of the world's largest healthcare companies. GSK Consumer Healthcare aims to become one of the world's most innovative, best performing, and trusted healthcare companies. Their goal is to improve lives through scientific innovation, build category-defining brands, and become Pakistan's first and best Fast Moving Consumer Healthcare Company." ["address_street"]=> string(28) "184 Liberty Corner Rd Ste 78" ["address_place"]=> string(6) "Warren" ["address_region"]=> string(10) "New Jersey" ["founding_date"]=> string(10) "1994-02-28" ["website_domain"]=> string(7) "gsk.com" ["website_url"]=> string(19) "https://www.gsk.com" ["industry_codes"]=> array(1) { [0]=> string(27) "Pharmaceutical Preparations" } ["employee_count"]=> int(300) ["article_count"]=> int(450) } ["articles"]=> array(9) { [0]=> array(7) { ["title_en"]=> string(62) "Mutual Advisors LLC Purchases 452 Shares of GSK plc (NYSE:GSK)" ["snippet_en"]=> string(219) "Mutual Advisors LLC boosted its position in shares of GSK plc (NYSE:GSK – Free Report) by 4.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission." ["url"]=> string(104) "https://www.defenseworld.net/2024/03/29/mutual-advisors-llc-purchases-452-shares-of-gsk-plc-nysegsk.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/5e6582b5-a950-4b28-8346-d30754db91b5" ["source"]=> string(16) "defenseworld.net" ["publication_date"]=> string(10) "2024-03-29" ["categories"]=> array(6) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(15) "Market Movement" [2]=> string(12) "Stock Market" [3]=> string(18) "General Investment" [4]=> string(11) "Regulations" [5]=> string(24) "Stock Research & Ratings" } } [1]=> array(7) { ["title_en"]=> string(73) "GSK’s turnover in Portugal “compares well” with that of Switzerland" ["snippet_en"]=> string(229) "GlaxoSmithKline (GSK) closed last year with a turnover of 106 million euros in Portugal, a market that is part of the pharmaceutical giant's top 10 in Europe, where it aims to continue growing and promises to increase investment." ["url"]=> string(104) "https://www.jornaldenegocios.pt/empresas/detalhe/faturacao-da-gsk-em-portugal-compara-bem-com-a-da-suica" ["image_url"]=> string(78) "https://images.businessradar.com/articles/e6b8e5eb-ab82-4185-b340-d2bb1eb0c1cf" ["source"]=> string(19) "jornaldenegocios.pt" ["publication_date"]=> string(10) "2024-03-26" ["categories"]=> array(1) { [0]=> string(18) "General Investment" } } [2]=> array(7) { ["title_en"]=> string(127) "Major Pharmaceutical Companies Adapt to Changing Consumer Health Market through Divestments and Strategic Shifts - News Biggest" ["snippet_en"]=> string(156) "Pfizer is selling approximately 630 million shares of Haleon, which will lower its stake in the company from 32% to around 24%. This transaction is expected" ["url"]=> string(137) "https://newsbiggest.com/major-pharmaceutical-companies-adapt-to-changing-consumer-health-market-through-divestments-and-strategic-shifts/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/eb0e8b0b-fd0c-42b6-abb5-5655bb4dc43a" ["source"]=> string(15) "newsbiggest.com" ["publication_date"]=> string(10) "2024-03-18" ["categories"]=> array(6) { [0]=> string(8) "spin-off" [1]=> string(25) "Business Model Resilience" [2]=> string(12) "Stock Market" [3]=> string(11) "Acquisition" [4]=> string(18) "General Investment" [5]=> string(24) "Stock Research & Ratings" } } [3]=> array(7) { ["title_en"]=> string(53) "GSK plc (NYSE:GSK) Shares Sold by Sei Investments Co." ["snippet_en"]=> string(300) "Sei Investments Co. decreased its position in GSK plc (NYSE:GSK - Free Report) by 28.9% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 633,530 shares of the pharmaceutical company's stock after se" ["url"]=> string(73) "https://www.marketbeat.com/instant-alerts/nyse-gsk-sec-filing-2024-03-10/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/c1d46a40-ff0b-419f-ba04-8b09ad6e7c00" ["source"]=> string(14) "marketbeat.com" ["publication_date"]=> string(10) "2024-03-10" ["categories"]=> array(5) { [0]=> string(31) "Financial Update/Profit Warning" [1]=> string(12) "Stock Market" [2]=> string(18) "General Investment" [3]=> string(11) "Regulations" [4]=> string(24) "Stock Research & Ratings" } } [4]=> array(7) { ["title_en"]=> string(109) "Business life - In La Chapelle-d'Angillon, 3C France benefits from investments in the pharmaceutical industry" ["snippet_en"]=> string(141) "In a booming pharmaceutical sector, the family business 3C France has won a big deal with the British giant GSK which is investing in France." ["url"]=> string(166) "https://www.leberry.fr/chapelle-d-angillon-18380/actualites/a-la-chapelle-d-angillon-3c-france-tire-profit-des-investissements-de-l-industrie-pharmaceutique_14463663/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/29509172-b68e-459c-9a0a-45833c78c838" ["source"]=> string(10) "leberry.fr" ["publication_date"]=> string(10) "2024-03-06" ["categories"]=> array(3) { [0]=> string(19) "Foreign Development" [1]=> string(18) "General Investment" [2]=> string(15) "Deals & Tenders" } } [5]=> array(7) { ["title_en"]=> string(32) "15 Best Drug Stocks To Invest In" ["snippet_en"]=> string(226) "In this article, we discuss the 15 best drug stocks to invest in. You can skip our detailed analysis of the drug and pharmaceutical sector and its outlook this year, and go directly to read the 5 Best Drug Stocks To Invest In." ["url"]=> string(72) "https://finance.yahoo.com/news/15-best-drug-stocks-invest-115103210.html" ["image_url"]=> string(78) "https://images.businessradar.com/articles/36157b4e-976d-4ef6-8c16-628914532602" ["source"]=> string(9) "yahoo.com" ["publication_date"]=> string(10) "2023-11-26" ["categories"]=> array(4) { [0]=> string(15) "Market Movement" [1]=> string(18) "General Investment" [2]=> string(12) "Stock Market" [3]=> string(24) "Stock Research & Ratings" } } [6]=> array(7) { ["title_en"]=> string(53) "GSK invests 4 million in 6,000 solar panels in Aranda" ["snippet_en"]=> string(206) "With this new project, the pharmaceutical multinational will generate more than 5,700 MWh per year in renewable energy, which represents 30% of the factory's consumption and a reduction of 1,500 tons of CO2" ["url"]=> string(138) "https://www.diariodeburgos.es/noticia/zdf88e4df-d008-d3a6-dffa90b09071c6ba/202311/gsk-invierte-en-aranda-4-millones-en-6000-placas-solares" ["image_url"]=> string(78) "https://images.businessradar.com/articles/4c9eb641-07c9-4e2e-8c0d-809393294272" ["source"]=> string(17) "diariodeburgos.es" ["publication_date"]=> string(10) "2023-11-04" ["categories"]=> array(10) { [0]=> string(22) "Sustainable Investment" [1]=> string(17) "Energy Management" [2]=> string(19) "Investment Requests" [3]=> string(18) "Expansion & Growth" [4]=> string(13) "GHG Emissions" [5]=> string(33) "Materials Sourcing and Efficiency" [6]=> string(6) "Energy" [7]=> string(19) "Green & Responsible" [8]=> string(18) "General Investment" [9]=> string(20) "Alternative Energies" } } [7]=> array(7) { ["title_en"]=> string(103) "GSK earns 1,023 million with the sale of 2.9% of the share capital of Haleon, manufacturer of Sensodyne" ["snippet_en"]=> string(184) "The British pharmaceutical company GlaxoSmithKline (GSK) has earned 885.6 million pounds (1,023 million euros) from the sale of a package of 270 million Haleon shares, equivalent to..." ["url"]=> string(142) "https://www.pressdigital.es/articulo/economia/2023-10-06/4465969-gsk-ingresa-1023-millones-venta-29-capital-social-haleon-fabricante-sensodyne" ["image_url"]=> string(78) "https://images.businessradar.com/articles/f5579800-6da8-420f-9b94-f16557b83d85" ["source"]=> string(15) "pressdigital.es" ["publication_date"]=> string(10) "2023-10-06" ["categories"]=> array(4) { [0]=> string(18) "General Investment" [1]=> string(10) "Divestment" [2]=> string(14) "Issuing Shares" [3]=> string(19) "Investment Requests" } } [8]=> array(7) { ["title_en"]=> string(118) "GSK earns 1,023 million with the sale of 2.9% of the share capital of Haleon, manufacturer of Sensodyne - Forbes Spain" ["snippet_en"]=> string(152) "The British pharmaceutical company GlaxoSmithKline (GSK) has earned 885.6 million pounds (1,023 million euros) with the sale of a package of 270 million" ["url"]=> string(139) "https://forbes.es/ultima-hora/347161/gsk-ingresa-1-023-millones-con-la-venta-de-un-29-del-capital-social-de-haleon-fabricante-de-sensodyne/" ["image_url"]=> string(78) "https://images.businessradar.com/articles/2277c941-5df1-4b3a-adc2-9222c12cdd86" ["source"]=> string(9) "forbes.es" ["publication_date"]=> string(10) "2023-10-06" ["categories"]=> array(3) { [0]=> string(18) "General Investment" [1]=> string(10) "Divestment" [2]=> string(19) "Investment Requests" } } } ["category_annotations"]=> array(30) { [0]=> array(2) { ["name"]=> string(13) "Collaboration" ["count"]=> int(28) } [1]=> array(2) { ["name"]=> string(8) "Epidemic" ["count"]=> int(26) } [2]=> array(2) { ["name"]=> string(12) "Stock Market" ["count"]=> int(26) } [3]=> array(2) { ["name"]=> string(5) "Legal" ["count"]=> int(21) } [4]=> array(2) { ["name"]=> string(11) "Acquisition" ["count"]=> int(20) } [5]=> array(2) { ["name"]=> string(18) "General Investment" ["count"]=> int(18) } [6]=> array(2) { ["name"]=> string(18) "Expansion & Growth" ["count"]=> int(17) } [7]=> array(2) { ["name"]=> string(24) "Quarterly/Annual Figures" ["count"]=> int(16) } [8]=> array(2) { ["name"]=> string(24) "Access and affordability" ["count"]=> int(15) } [9]=> array(2) { ["name"]=> string(5) "Award" ["count"]=> int(14) } [10]=> array(2) { ["name"]=> string(14) "Product Launch" ["count"]=> int(14) } [11]=> array(2) { ["name"]=> string(31) "Financial Update/Profit Warning" ["count"]=> int(13) } [12]=> array(2) { ["name"]=> string(5) "R & D" ["count"]=> int(12) } [13]=> array(2) { ["name"]=> string(25) "Business Model Resilience" ["count"]=> int(11) } [14]=> array(2) { ["name"]=> string(10) "Litigation" ["count"]=> int(10) } [15]=> array(2) { ["name"]=> string(12) "Board Change" ["count"]=> int(10) } [16]=> array(2) { ["name"]=> string(15) "Market Movement" ["count"]=> int(9) } [17]=> array(2) { ["name"]=> string(20) "Business Development" ["count"]=> int(9) } [18]=> array(2) { ["name"]=> string(13) "Data Security" ["count"]=> int(8) } [19]=> array(2) { ["name"]=> string(16) "Customer Welfare" ["count"]=> int(7) } [20]=> array(2) { ["name"]=> string(15) "Deals & Tenders" ["count"]=> int(7) } [21]=> array(2) { ["name"]=> string(19) "Economic Conditions" ["count"]=> int(6) } [22]=> array(2) { ["name"]=> string(46) "Management of Legal and Regulatory Environment" ["count"]=> int(6) } [23]=> array(2) { ["name"]=> string(6) "Crisis" ["count"]=> int(6) } [24]=> array(2) { ["name"]=> string(21) "Cultural developments" ["count"]=> int(6) } [25]=> array(2) { ["name"]=> string(7) "Layoffs" ["count"]=> int(6) } [26]=> array(2) { ["name"]=> string(10) "Divestment" ["count"]=> int(6) } [27]=> array(2) { ["name"]=> string(24) "Employee Health & Safety" ["count"]=> int(6) } [28]=> array(2) { ["name"]=> string(17) "Academic Research" ["count"]=> int(5) } [29]=> array(2) { ["name"]=> string(24) "Stock Research & Ratings" ["count"]=> int(5) } } } 4abba-us-gsk-consumer-health-inc